Literature DB >> 15266244

Conference report--at the forefront of cancer research: preclinical data highlights of annual meeting of the 95th American Association for Cancer Research; March 27-31, 2004; Orlando, Florida.

Sara M Mariani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15266244      PMCID： PMC1395770     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  10 in total

Review 1.  The role of bcl-2 in lymphoid differentiation and neoplastic transformation.

Authors:  A Strasser; A W Harris; S Cory
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

2.  Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control.

Authors:  Jene Choi; Bonnie Nannenga; Oleg N Demidov; Dmitry V Bulavin; Austin Cooney; Cory Brayton; Yongxin Zhang; Innocent N Mbawuike; Allan Bradley; Ettore Appella; Lawrence A Donehower
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

Review 3.  Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins.

Authors:  H Puthalakath; A Strasser
Journal:  Cell Death Differ       Date:  2002-05       Impact factor: 15.828

4.  Small-molecule antagonists of p53-MDM2 binding: research tools and potential therapeutics.

Authors:  Lyubomir T Vassilev
Journal:  Cell Cycle       Date:  2004-04-01       Impact factor: 4.534

Review 5.  Inhibition of the p53-MDM2 interaction: targeting a protein-protein interface.

Authors:  Patrick Chène
Journal:  Mol Cancer Res       Date:  2004-01       Impact factor: 5.852

6.  Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway.

Authors:  Dmitry V Bulavin; Crissy Phillips; Bonnie Nannenga; Oleg Timofeev; Larry A Donehower; Carl W Anderson; Ettore Appella; Albert J Fornace
Journal:  Nat Genet       Date:  2004-02-29       Impact factor: 38.330

7.  In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.

Authors:  Lyubomir T Vassilev; Binh T Vu; Bradford Graves; Daisy Carvajal; Frank Podlaski; Zoran Filipovic; Norman Kong; Ursula Kammlott; Christine Lukacs; Christian Klein; Nader Fotouhi; Emily A Liu
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

Review 8.  Cell cycle regulatory functions of the human oncoprotein MDM2.

Authors:  Swati Palit Deb
Journal:  Mol Cancer Res       Date:  2003-12       Impact factor: 5.852

Review 9.  Targeting Bcl-2 and Bcl-XL with nonpeptidic small-molecule antagonists.

Authors:  Shaomeng Wang; Dajun Yang; Marc E Lippman
Journal:  Semin Oncol       Date:  2003-10       Impact factor: 4.929
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.